1/M/50 | L: Lung (single nodule) | AL-λ | (-)/NE | Asymptomatic | 15 | None | 66% | 86% |
2/F/69 | L: Lung (single nodule) | AL-λ | IgG-λ/NE | Asymptomatic | None | MGUS, DM | 137% | 71% |
3/M/57 | L: Lung (multiple nodules) | AL-λ | (-)/NE | Asymptomatic | 10 | None | 113% | 71% |
4/M/74 | L: Lung (multiple nodules) | AL-κ | IgG-κ/NE | Asymptomatic | 10 | Pulmonary MALT lymphoma, MGUS | 119% | 69% |
5/F/60 | L: Lung (multiple nodules) | AL-κ | (-)/NE | Asymptomatic | None | Sjögren's syndrome | 115% | 79% |
6/F/72 | L: Lung (multiple nodules) | AL-κ | NE/NE | Asymptomatic | None | Sjögren's syndrome, RA, NSIP, bronchiolitis | 72% | 78% |
7/M/71 | L: Lung (multiple nodules) | AL-λ | (-)/NE | Diverticulitis of colon | 49 | None | 89% | 62% |
8/M/73 | L: Trachea-bronchus | AL-κ | (-)/NE | Bronchoscopy at CHP | None | CHP | 98% | 76% |
9/F/63 | L: Mediastinal lymph node | AL-λ | IgG-λ/5.73 | Asymptomatic | None | MGUS | 83% | 75% |
10/M/61 | L: Pleura | AL-κ | Bence Jones-κ/NE | Dyspnoea, pleural effusion | 60 | MM, MM kidney, myeloma cell invasion to pleura | NE | NE |
11/F/72 | S: Lung (DASA), mediastinal lymph node, pleura, heart | AL-λ | (-)/0.15 | Dyspnoea | None | None | 73% | 85% |
12/F/71 | S: Lung (DASA), kidney, heart, rectum | AL-λ | IgG-λ, Bence Jones-λ/NE | Haemosputum, cough, dyspnoea | None | MM, cerebral infarction | 74% | 80% |
13/F/62 | S: Lung (DASA), kidney, heart | AA | (-)/NE | Fever, dyspnoea of PCP | None | RA、PCP | NE | NE |
14/M/79 | S: Lung (DASA), heart, carpal tunnel | ATTRwt | IgG-κ/NE | Haemosputum | 35 | ATTRwt, MGUS, AF, pacemaker, carpal tunnel syndrome | 85% | 72% |
15/F/84 | S: Lung (DASA), heart | ATTRwt | (-)/0.94 | Asymptomatic | None | Lung cancer | 55% | 73% |
16/M/75 | S: Mediastinal lymph node, kidney, heart, rectum | AL-λ | IgM-λ, Bence Jones-λ/0.05 | Dyspnoea | 50 | Waldenström macroglobulinemia, DM | 106% | 75% |